High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$19.4M
$19,402,207
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KRYS
S
Krystal Biotech, Inc.
JANNEY DANIEL
• Director
10b5-1 SellΔOwn -11.1%
2026-02-27
$2,597,481Large
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 SellΔOwn -11.1%
|
2026-02-27 | $2,597,481Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-27 | $655,343 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-26 | $1,404,760Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-26 | $728,919 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-25 | $192,500 | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
JANNEY DANIEL
• Director
10b5-1 SellΔOwn -50.6%
2026-02-24
$3,116,310Large
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 SellΔOwn -50.6%
|
2026-02-24 | $3,116,310Large | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
JANNEY DANIEL
• Director
10b5-1 SellΔOwn -58.6%
2026-02-24
$1,788,079Large
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 SellΔOwn -58.6%
|
2026-02-24 | $1,788,079Large | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
JANNEY DANIEL
• Director
10b5-1 SellΔOwn -84.2%
2026-02-24
$1,065,924Large
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 SellΔOwn -84.2%
|
2026-02-24 | $1,065,924Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 SellΔOwn -49.8%
|
2026-02-24 | $99,836 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $101,118 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $16,309 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
Other
|
2026-02-24 | $93,222 | M | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $425,919 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $1,156,879Large | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $505,597 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $449,747 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $250,636 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $666,627 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $238,136 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $149,594 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $457,728 | S | Form 4 |
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 Sell
|
2026-02-24 | $942,878 | S | Form 4 |
|
KRYS
S
Krystal Biotech, Inc.
JANNEY DANIEL
• Director
10b5-1 SellΔOwn -28.1%
2026-02-24
$2,391,885Large
|
||||||
| KRYS |
Krystal Biotech, Inc.
|
Director
10b5-1 SellΔOwn -28.1%
|
2026-02-24 | $2,391,885Large | S | Form 4 |